vs
null（GPRO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是null的1.0倍（$207.3M vs $201.7M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 0.4%），null自由现金流更多（$15.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 13.9%）
GoPro, Inc.是2002年由尼克·伍德曼创立的美国科技企业，最初注册名为伍德曼实验室，总部坐落于加利福尼亚州圣马特奥。该公司主营运动相机生产制造，同时还自主开发配套移动端应用与视频编辑软件。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GPRO vs RARE — 直观对比
营收规模更大
RARE
是对方的1.0倍
$201.7M
营收增速更快
RARE
高出25.5%
0.4%
自由现金流更多
GPRO
多$115.7M
$-100.8M
两年增速更快
RARE
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $201.7M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | 31.8% | — |
| 营业利润率 | -4.1% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 0.4% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-0.06 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPRORARE
| Q4 25 | $201.7M | $207.3M | ||
| Q3 25 | $162.9M | $159.9M | ||
| Q2 25 | $152.6M | $166.5M | ||
| Q1 25 | $134.3M | $139.3M | ||
| Q4 24 | $200.9M | $164.6M | ||
| Q3 24 | $258.9M | $139.5M | ||
| Q2 24 | $186.2M | $147.0M | ||
| Q1 24 | $155.5M | $108.8M |
净利润GPRORARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-21.3M | $-180.4M | ||
| Q2 25 | $-16.4M | $-115.0M | ||
| Q1 25 | $-46.7M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $-8.2M | $-133.5M | ||
| Q2 24 | $-47.8M | $-131.6M | ||
| Q1 24 | $-339.1M | $-170.7M |
毛利率GPRORARE
| Q4 25 | 31.8% | — | ||
| Q3 25 | 35.1% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 32.1% | — | ||
| Q4 24 | 34.7% | — | ||
| Q3 24 | 35.5% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 34.1% | — |
营业利润率GPRORARE
| Q4 25 | -4.1% | -54.7% | ||
| Q3 25 | -9.8% | -106.9% | ||
| Q2 25 | -9.2% | -64.8% | ||
| Q1 25 | -33.7% | -102.6% | ||
| Q4 24 | -19.5% | -74.3% | ||
| Q3 24 | -3.1% | -94.6% | ||
| Q2 24 | -25.0% | -79.1% | ||
| Q1 24 | -26.6% | -151.9% |
净利率GPRORARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | -13.0% | -112.8% | ||
| Q2 25 | -10.8% | -69.0% | ||
| Q1 25 | -34.8% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | -3.2% | -95.7% | ||
| Q2 24 | -25.7% | -89.5% | ||
| Q1 24 | -218.1% | -156.8% |
每股收益（稀释后）GPRORARE
| Q4 25 | $-0.06 | $-1.28 | ||
| Q3 25 | $-0.13 | $-1.81 | ||
| Q2 25 | $-0.10 | $-1.17 | ||
| Q1 25 | $-0.30 | $-1.57 | ||
| Q4 24 | $-0.22 | $-1.34 | ||
| Q3 24 | $-0.05 | $-1.40 | ||
| Q2 24 | $-0.31 | $-1.52 | ||
| Q1 24 | $-2.24 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.7M | $421.0M |
| 总债务越低越好 | $44.3M | — |
| 股东权益账面价值 | $76.5M | $-80.0M |
| 总资产 | $428.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.58× | — |
8季度趋势，按日历期对齐
现金及短期投资GPRORARE
| Q4 25 | $49.7M | $421.0M | ||
| Q3 25 | $152.8M | $202.5M | ||
| Q2 25 | $58.6M | $176.3M | ||
| Q1 25 | $69.6M | $127.1M | ||
| Q4 24 | $102.8M | $174.0M | ||
| Q3 24 | $130.2M | $150.6M | ||
| Q2 24 | $133.0M | $480.7M | ||
| Q1 24 | $133.7M | $112.3M |
总债务GPRORARE
| Q4 25 | $44.3M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $93.1M | — | ||
| Q2 24 | $92.9M | — | ||
| Q1 24 | $92.7M | — |
股东权益GPRORARE
| Q4 25 | $76.5M | $-80.0M | ||
| Q3 25 | $80.5M | $9.2M | ||
| Q2 25 | $97.9M | $151.3M | ||
| Q1 25 | $110.0M | $144.2M | ||
| Q4 24 | $151.7M | $255.0M | ||
| Q3 24 | $183.9M | $346.8M | ||
| Q2 24 | $184.7M | $432.4M | ||
| Q1 24 | $224.9M | $140.3M |
总资产GPRORARE
| Q4 25 | $428.0M | $1.5B | ||
| Q3 25 | $538.6M | $1.2B | ||
| Q2 25 | $439.0M | $1.3B | ||
| Q1 25 | $462.5M | $1.3B | ||
| Q4 24 | $543.7M | $1.5B | ||
| Q3 24 | $661.6M | $1.5B | ||
| Q2 24 | $556.8M | $1.6B | ||
| Q1 24 | $575.8M | $1.3B |
负债/权益比GPRORARE
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.41× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $15.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 7.4% | -48.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-24.0M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流GPRORARE
| Q4 25 | $15.6M | $-99.8M | ||
| Q3 25 | $12.2M | $-91.4M | ||
| Q2 25 | $8.8M | $-108.3M | ||
| Q1 25 | $-57.2M | $-166.5M | ||
| Q4 24 | $-25.1M | $-79.3M | ||
| Q3 24 | $-2.2M | $-67.0M | ||
| Q2 24 | $605.0K | $-77.0M | ||
| Q1 24 | $-98.4M | $-190.7M |
自由现金流GPRORARE
| Q4 25 | $15.0M | $-100.8M | ||
| Q3 25 | $11.2M | $-92.7M | ||
| Q2 25 | $8.3M | $-110.7M | ||
| Q1 25 | $-58.5M | $-167.8M | ||
| Q4 24 | $-25.5M | $-79.5M | ||
| Q3 24 | $-4.2M | $-68.6M | ||
| Q2 24 | $-111.0K | $-79.0M | ||
| Q1 24 | $-99.4M | $-193.9M |
自由现金流率GPRORARE
| Q4 25 | 7.4% | -48.6% | ||
| Q3 25 | 6.9% | -58.0% | ||
| Q2 25 | 5.4% | -66.5% | ||
| Q1 25 | -43.5% | -120.5% | ||
| Q4 24 | -12.7% | -48.3% | ||
| Q3 24 | -1.6% | -49.2% | ||
| Q2 24 | -0.1% | -53.7% | ||
| Q1 24 | -63.9% | -178.2% |
资本支出强度GPRORARE
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.6% | 0.8% | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.8% | 1.2% | ||
| Q2 24 | 0.4% | 1.4% | ||
| Q1 24 | 0.6% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPRO
| Subscription And Services | $106.3M | 53% |
| Other | $95.4M | 47% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
